RFA
DARE icon

Reilly Financial Advisors’s Dare Bioscience DARE Stock Holding History

Reilly Financial Advisors’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-206
Closed -$5K – 944
2021
Q2 		$5K Hold
206
– – ﹤0.01% 786
2021
Q1 		$4K Sell
206
-344
-63% -$8.39K ﹤0.01% 815
2020
Q4 		$9K Hold
550
– – ﹤0.01% 638
2020
Q3 		$7K Buy
+550
New +$7.33K ﹤0.01% 619
2017
Q1 		– Sell
-2
Closed – – 930
2016
Q4 		$0 Hold
2
– – ﹤0.01% 848
2016
Q3 		$0 Hold
2
– – ﹤0.01% 846
2016
Q2 		$0 Hold
2
– – ﹤0.01% 839
2016
Q1 		$1K Hold
2
– – ﹤0.01% 1116
2015
Q4 		$1K Hold
2
– – ﹤0.01% 1125
2015
Q3 		$1K Hold
2
– – ﹤0.01% 1197
2015
Q2 		$1K Hold
2
– – ﹤0.01% 1285
2015
Q1 		$2K Buy
+2
New +$1.94K ﹤0.01% 1166

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.95B AUM 22.17% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Reilly Financial Advisors's DARE Position: Q3 2021 in Review

Reilly Financial Advisors sold out of Dare Bioscience (DARE) in Q3 2021, closing a stake of 206 shares — an estimated $5K sold.

Reilly Financial Advisors first reported a position in DARE in Q1 2015 and held it in 12 quarters. The position peaked at $9K in Q4 2020. 37 funds tracked by Wall St. Rank hold DARE as of Q3 2021.

  • Reilly Financial Advisors reported no remaining Dare Bioscience position as of Q3 2021 after selling out during the quarter.
  • Reilly Financial Advisors sold 206 Dare Bioscience shares in Q3 2021, an estimated $5K.
  • Reilly Financial Advisors first reported a position in Dare Bioscience in Q1 2015 and held it in 12 quarters.
  • Reilly Financial Advisors's Dare Bioscience position peaked at $9K in Q4 2020.
  • 37 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2021.

Based on Reilly Financial Advisors's 13F filing for Q3 2021, filed 19 Oct 2021.